Source: administrator
On August 18, 2021, the third Branch of Beijing Municipal Food and Drug Administration commissioned two teachers from China Medical Equipment Huaguang to conduct a one-day on-site inspection and guidance work for our company.
During the inspection, the person in charge of Ruxin technology warmly received and reported the work. He introduced the overall situation of the company to the two teachers successively, including the main products, product advantages, and business development.
A symposium
During this period, the two teachers conducted in-depth inspection and guidance on the operation of the quality system of our company by means of reading materials, consulting records and inquiring on the spot. At the same time, the potential risks and hidden dangers were seriously investigated.
Subsequently, the two teachers of the inspection team went to the production workshop, clean workshop, warehouse and other production places of Ruxin Technology to check the production situation of our company in all aspects.
The inspection team checked the situation on the site
In the process of accepting the inspection, our department staff actively cooperate with the work of the inspection team, according to the need to provide relevant materials, and a detailed introduction to the site.
Through this inspection and guidance, Nuxin technology and all staff once again made clear the importance of product quality and safety, and also conducted an in-depth analysis of the non-conformance items and guidance opinions proposed by teachers, and will rectify within a time limit as required.
The person in charge of our company introduces the situation on site
In the future, our company will continue to improve the quality of products in accordance with laws, regulations and relevant standards and requirements, while constantly improving the innovation strength, practice medical device enterprise responsibility, further strengthen the construction of production quality management system, and contribute to the high-quality development of the medical and health industry.